tiprankstipranks
Harmony Biosciences Holdings (HRMY)
NASDAQ:HRMY
US Market
Holding HRMY?
Track your performance easily

Harmony Biosciences Holdings (HRMY) Financial Statements

213 Followers

Harmony Biosciences Holdings Financial Overview

Harmony Biosciences Holdings's market cap is currently ―. The company's EPS TTM is $2.112; its P/E ratio is 16.23; Harmony Biosciences Holdings is scheduled to report earnings on February 19, 2025, and the estimated EPS forecast is $0.68. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue$ 186.04M$ 172.81M$ 154.62M$ 168.41M$ 160.27M
Gross Profit$ 143.26M$ 140.67M$ 127.13M$ 125.26M$ 127.97M
EBIT$ 66.52M$ 26.10M$ 56.32M-$ 58.84M
EBITDA$ 72.66M$ 32.92M$ 62.03M-$ 66.20M
Net Income Common Stockholders$ 46.09M$ 11.59M$ 38.33M$ 26.61M$ 38.46M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 410.48M$ 346.91M$ 372.35M$ 353.46M$ 370.67M
Total Assets$ 928.13M$ 858.38M$ 846.99M$ 811.45M$ 777.77M
Total Debt$ 182.85M$ 186.42M$ 190.00M$ 193.57M$ 197.13M
Net Debt$ -227.63M$ -160.49M$ -182.35M$ -159.89M$ -173.54M
Total Liabilities$ 331.33M$ 319.80M$ 331.59M$ 344.46M$ 296.43M
Stockholders Equity$ 596.80M$ 538.58M$ 515.39M$ 466.99M$ 481.33M
Cash Flow-
Free Cash Flow$ 70.50M$ 41.98M$ 31.14M-$ 63.10M
Operating Cash Flow$ 70.50M$ 42.62M$ 31.14M$ 76.67M$ 63.10M
Investing Cash Flow$ 745.00K$ -54.86M$ -6.19M$ -36.06M$ -813.00K
Financing Cash Flow$ -1.18M$ -3.45M$ -3.63M$ -53.52M$ -55.10M
Currency in USD

Harmony Biosciences Holdings Earnings and Revenue History

Harmony Biosciences Holdings Debt to Assets

Harmony Biosciences Holdings Cash Flow

Harmony Biosciences Holdings Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis